المؤلفون: Dupere-Richer D; University of Florida, Gainesville, Florida, United States., Riva A; University of Florida, Gainesville, Florida, United States., Barwick BG; Emory University, Atlanta, Georgia, United States., Maji S; University of Florida, Gainesville, Florida, United States., Casellas Roman H; University of Florida, Gainesville, Florida, United States., Li J; University of Florida, Gainesville, Florida, United States., De U; University of Florida, Gainesville, Florida, United States., Sobh A; University of Florida, Gainesville, Florida, United States., Quickstad G; University of Florida, Gainesville, Florida, United States., Piper C; University of Florida, Englewood, Colorado, United States., Kulis M; IDIBAPS, Barcelona, Spain., Ezponda T; CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain., Martín-Subero JI; Department of Pathology, Hematopathology Section, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain, Barcelona, Spain., Tonon G; IRCCS San Raffaele Scientific Institute, Milan, Italy., Zhang W; University of Florida, Gainesville, Florida, United States., Mitsiades CS; Dana-Farber Cancer Institute, Harvard Med. School, Boston, Massachusetts, United States., Boise LH; Emory University School of Medicine, Atlanta, Georgia, United States., Bennett RL; University of Florida, Gainesville, Florida, United States., Licht JD; The University of Florida, Gainesville, Florida, United States.

المصدر: Blood [Blood] 2024 Jul 24. Date of Electronic Publication: 2024 Jul 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

المؤلفون: Sobh A; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Encinas E; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Patel A; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Surapaneni G; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Bonilla E; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Kaestner C; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Poullard J; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Clerio M; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Vasan K; Department of Medicine, Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL., Freeman T; Center for ViroScience and Cure, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Lv D; Department of Biochemistry and Structural Biology, The University of Texas Health Science Center San Antonio, San Antonio, TX., Dupéré-Richer D; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Riva A; Interdisciplinary Center for Biotechnology Research, The University of Florida, Gainesville, FL., Barwick BG; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Zhou D; Department of Biochemistry and Structural Biology, The University of Texas Health Science Center San Antonio, San Antonio, TX., Boise LH; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Kim B; Center for ViroScience and Cure, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Bennett RL; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL., Chandel NS; Department of Medicine, Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL., Licht JD; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.

المصدر: Blood [Blood] 2024 Jul 18; Vol. 144 (3), pp. 283-295.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/genetics , Multiple Myeloma*/metabolism , Multiple Myeloma*/pathology , Histone-Lysine N-Methyltransferase*/genetics , Histone-Lysine N-Methyltransferase*/metabolism , Translocation, Genetic* , Adenylate Kinase*/metabolism , Adenylate Kinase*/genetics, Humans ; Chromosomes, Human, Pair 14/genetics ; Epigenome ; Chromosomes, Human, Pair 4/genetics ; Carbon/metabolism ; Cell Line, Tumor ; Repressor Proteins

المؤلفون: Zhang B; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Liu M; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China., Mai F; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China., Li X; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China.; Inner Mongolia Institute of Quality and Standardization, Inner Mongolia Administration for Market Regulation, Hohhot, China., Wang W; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China., Huang Q; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China., Du X; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China., Ding W; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China., Li Y; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Barwick BG; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Ni JJ; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Osunkoya AO; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Departments of Pathology and Urology, Emory University School of Medicine, Atlanta, Georgia, USA., Chen Y; Key Laboratory of Major Metabolic Diseases and Nutritional Regulation of Anhui Department of Education, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, China., Zhou W; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Xia S; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Dong JT; Department of Human Cell Biology and Genetics, Southern University of Science and Technology, School of Medicine, Shenzhen, Guangdong, China.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 May 23; Vol. 134 (14). Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/genetics , PTEN Phosphohydrolase*/metabolism , PTEN Phosphohydrolase*/genetics , Cancer-Associated Fibroblasts*/metabolism , Cancer-Associated Fibroblasts*/pathology , Kruppel-Like Transcription Factors*/metabolism , Kruppel-Like Transcription Factors*/genetics, Male ; Humans ; Acetylation ; Animals ; Mice ; Cellular Reprogramming ; Cell Line, Tumor

المؤلفون: Kasap C; Dept. of Medicine, Division of Hematology/Oncology, University of California, San Francisco, CA.; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Izgutdina A; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Patiño-Escobar B; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Kang A; Dept. of Laboratory Medicine, University of California, San Francisco, CA.; Medical Scientist Training Program, University of California, San Francisco, CA., Chilakapati N; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Akagi N; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Johnson H; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Rashid T; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Werner J; Dept. of Pediatrics, Division of Oncology, University of California, San Francisco, CA., Barpanda A; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Geng H; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Lin YT; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Rampersaud S; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Gil-Alós D; Dept. of Laboratory Medicine, University of California, San Francisco, CA.; Dept of Hematology, Hospital 12 de Octubre, Madrid, Spain., Sobh A; University of Florida Health Cancer Center, The University of Florida Cancer and Genetics Research Complex, Gainesville, Florida.; Division of Hematology/Oncology, The University of Florida College of Medicine, Gainesville, Florida., Dupéré-Richer D; University of Florida Health Cancer Center, The University of Florida Cancer and Genetics Research Complex, Gainesville, Florida.; Division of Hematology/Oncology, The University of Florida College of Medicine, Gainesville, Florida., Wicaksono G; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Kawehi Kelii KM; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Dalal R; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA., Ramos E; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Vijayanarayanan A; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Salangsang F; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Phojanakong P; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Serrano JAC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Zakraoui O; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Tariq I; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Steri V; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Shanmugam M; Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA., Boise LH; Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA., Kortemme T; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA.; Chan Zuckerberg Biohub San Francisco, San Francisco, CA., Stieglitz E; Dept. of Pediatrics, Division of Oncology, University of California, San Francisco, CA., Licht JD; University of Florida Health Cancer Center, The University of Florida Cancer and Genetics Research Complex, Gainesville, Florida.; Division of Hematology/Oncology, The University of Florida College of Medicine, Gainesville, Florida., Karlon WJ; Dept. of Laboratory Medicine, University of California, San Francisco, CA., Barwick BG; Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA., Wiita AP; Dept. of Laboratory Medicine, University of California, San Francisco, CA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Chan Zuckerberg Biohub San Francisco, San Francisco, CA.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 28. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Dupéré-Richer D, Riva A, Maji S, Barwick BG, Román HC, Sobh A, Quickstad G, Li J, De U, Piper C, Kulis M, Ezponda T, Martin-Subero JI, Tonon G, Zhang W, Mitsiades CS, Boise LH, Bennett RL, Licht JD

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 12. Date of Electronic Publication: 2024 Feb 12.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Barwick BG; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Jung D; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Patton JC; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Maity R; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Tagoug I; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Stein CK; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona., Tilmont R; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Leblay N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Ahn S; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Lee H; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada., Welsh SJ; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona., Riggs DL; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona., Stong N; Translational Medicine, Bristol Myers Squibb, Summit, New Jersey., Flynt E; Predictive Sciences, Bristol Myers Squibb, Summit, New Jersey., Thakurta A; Oxford Centre for Translational Myeloma Research, University of Oxford, Oxford, United Kingdom., Keats JJ; Translational Genomics Research Institute, Phoenix, Arizona., Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Bergsagel PL; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona., Boise LH; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, -Canada.

المصدر: Blood cancer discovery [Blood Cancer Discov] 2024 Jan 08; Vol. 5 (1), pp. 56-73.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/genetics, Humans ; Bromodomain Containing Proteins ; Cell Cycle Proteins ; Immunomodulating Agents ; Neoplasm Recurrence, Local ; Nuclear Proteins ; Proto-Oncogene Proteins c-ets/genetics ; Transcription Factors/genetics ; Ubiquitin-Protein Ligases/physiology ; Ubiquitin-Protein Ligases/therapeutic use

المؤلفون: Welsh SJ; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Barwick BG; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Meermeier EW; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Riggs DL; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Shi CX; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Zhu YX; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Sharik ME; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Du MT; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Abrego Rocha LD; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Garbitt VM; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Stein CK; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Petit JL; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Meurice N; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Tafoya Alvarado Y; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Fonseca R; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Todd KT; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Brown S; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Hammond ZJ; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Cuc NH; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Wittenberg C; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Herzog C; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Roschke AV; Genetics Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Demchenko YN; Genetics Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Chen WD; Genetics Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Li P; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland., Liao W; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland., Leonard WJ; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland., Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Bahlis NJ; Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada.; Charbonneau Cancer Research Institute, University of Calgary, Calgary, Canada., Neri P; Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada.; Charbonneau Cancer Research Institute, University of Calgary, Calgary, Canada., Boise LH; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Chesi M; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona., Bergsagel PL; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.

المصدر: Blood cancer discovery [Blood Cancer Discov] 2024 Jan 08; Vol. 5 (1), pp. 34-55.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/genetics, Humans ; Lenalidomide/pharmacology ; Lenalidomide/therapeutic use ; Transcription Factor AP-1/therapeutic use ; Drug Combinations ; Immunomodulating Agents

المؤلفون: Leblay N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Ahn S; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.; Department of Chemical and Petroleum Engineering, University of Calgary, Calgary, AB, Canada., Tilmont R; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Poorebrahim M; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Maity R; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Lee H; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Barakat E; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Alberge JB; Dana-Farber Cancer Institute, Boston, MA., Sinha S; Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada., Jaffer A; Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada., Barwick BG; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.; Winship Cancer Institute, Emory University, Atlanta, GA., Boise LH; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.; Winship Cancer Institute, Emory University, Atlanta, GA., Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

المصدر: Blood [Blood] 2024 Jan 04; Vol. 143 (1), pp. 42-56.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Antineoplastic Agents*/therapeutic use, Humans ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Epigenesis, Genetic ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use

المؤلفون: Moreno CS; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.; Department of Biomedical Informatics, Emory University, Atlanta, GA 30322, USA., Winham CL; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA., Alemozaffar M; Department of Urology, Emory University, Atlanta, GA 30322, USA., Klein ER; Emory College of Arts and Sciences, Atlanta, GA 30322, USA., Lawal IO; Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA., Abiodun-Ojo OA; Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA., Patil D; Department of Urology, Emory University, Atlanta, GA 30322, USA., Barwick BG; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA., Huang Y; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322, USA., Schuster DM; Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA., Sanda MG; Department of Urology, Emory University, Atlanta, GA 30322, USA., Osunkoya AO; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.; Department of Urology, Emory University, Atlanta, GA 30322, USA.

المصدر: Cancers [Cancers (Basel)] 2023 Nov 30; Vol. 15 (23). Date of Electronic Publication: 2023 Nov 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: de Matos Simoes R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Shirasaki R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Downey-Kopyscinski SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Matthews GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Barwick BG; Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA, USA., Gupta VA; Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA, USA., Dupéré-Richer D; University of Florida Health Cancer Center, Gainesville, FL, USA., Yamano S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Hu Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Sheffer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Dhimolea E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Dashevsky O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Gandolfi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Ishiguro K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Meyers RM; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Bryan JG; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Dharia NV; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hengeveld PJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Brüggenthies JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Tang H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Sievers QL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Glassner BJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Ott CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Kwiatkowski NP; Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Levy J; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Keats JJ; Translational Genomics Research Institute, Phoenix, AZ, USA., Groen RWJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Gray NS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Culhane AC; Department of Data Sciences, Dana-Farber Cancer Institute & Harvard School of Public Health, Boston, MA, USA.; Limerick Digital Cancer Research Center, Health Research Institute, School of Medicine, University of Limerick, Limerick, Ireland., McFarland JM; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Dempster JM; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Licht JD; University of Florida Health Cancer Center, Gainesville, FL, USA., Boise LH; Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Vazquez F; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. vazquez@broadinstitute.org., Tsherniak A; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. aviad@broadinstitute.org., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. constantine_mitsiades@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. constantine_mitsiades@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. constantine_mitsiades@dfci.harvard.edu.; Ludwig Center at Harvard, Boston, MA, USA. constantine_mitsiades@dfci.harvard.edu.

المصدر: Nature cancer [Nat Cancer] 2023 May; Vol. 4 (5), pp. 754-773. Date of Electronic Publication: 2023 May 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/genetics, Humans ; Genomics ; Genome ; Clustered Regularly Interspaced Short Palindromic Repeats/genetics